Company Comparison
Carmat vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Carmat | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Vélizy-Villacoublay, France | Lagos, Nigeria |
| Founded | 2008 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | €63M | $45M |
| Valuation | — | — |
What They Build
Carmat
Carmat develops artificial heart devices designed to replace the function of a failing heart in patients with end-stage heart failure.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Carmat
Sector Overlap
Both Carmat and 54gene operate in Biotech.
Browse all Biotech companies →